{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T00:34:18Z","timestamp":1795048458056,"version":"4.10.2"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007229","name":"Harvard University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007229","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007299","name":"Harvard Catalyst","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL 1TR002541"],"award-info":[{"award-number":["UL 1TR002541"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ygyno.2019.04.003","type":"journal-article","created":{"date-parts":[[2019,4,30]],"date-time":"2019-04-30T17:30:13Z","timestamp":1556645413000},"page":"8-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Financial toxicity in gynecologic oncology"],"prefix":"10.1016","volume":"154","author":[{"given":"Sara","family":"Bouberhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5262-1245","authenticated-orcid":false,"given":"Meghan","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne","family":"Erlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Stack-Dunnbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary K.","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laureen","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Awtrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.","family":"Dalrymple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong W.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele R.","family":"Hacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine M.","family":"Esselen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.ygyno.2019.04.003_bb0005","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1002\/cncr.28814","article-title":"The development of a financial toxicity patient-reported outcome in cancer: The COST measure","volume":"120","author":"de Souza","year":"2014","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2019.04.003_bb0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/cncr.30369","article-title":"Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST)","volume":"123","author":"de Souza","year":"2017","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2019.04.003_bb0015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1377\/hlthaff.2012.1263","article-title":"Washington State cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis","volume":"32","author":"Ramsey","year":"2013","journal-title":"Health Aff (Millwood)"},{"issue":"9","key":"10.1016\/j.ygyno.2019.04.003_bb0020","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","article-title":"Financial insolvency as a risk factor for early mortality among patients with cancer","volume":"34","author":"Ramsey","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.ygyno.2019.04.003_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1200\/JOP.2014.001542","article-title":"Population-based assessment of cancer survivors' financial burden and quality of life: a prospective cohort study","volume":"11","author":"Zafar","year":"2015","journal-title":"J Oncol Pract"},{"issue":"5","key":"10.1016\/j.ygyno.2019.04.003_bb0030","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JOP.2013.001322","article-title":"Impact of financial burden of cancer on survivors' quality of life","volume":"10","author":"Fenn","year":"2014","journal-title":"J Oncol Pract"},{"issue":"15","key":"10.1016\/j.ygyno.2019.04.003_bb0035","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","article-title":"Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer","volume":"34","author":"Lathan","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.04.003_bb0040","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1634\/theoncologist.2013-0374","article-title":"Self-reported financial burden and satisfaction with care among patients with cancer","volume":"19","author":"Chino","year":"2014","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.ygyno.2019.04.003_bb0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","article-title":"The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience","volume":"18","author":"Zafar","year":"2013","journal-title":"Oncologist"},{"issue":"10","key":"10.1016\/j.ygyno.2019.04.003_bb0050","doi-asserted-by":"crossref","first-page":"e408-16","DOI":"10.1016\/S2352-3026(15)00151-9","article-title":"Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study","volume":"2","author":"Huntington","year":"2015","journal-title":"Lancet Haematol"},{"issue":"36","key":"10.1016\/j.ygyno.2019.04.003_bb0055","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1200\/JCO.2016.67.4184","article-title":"Factors associated with tyrosine kinase inhibitor initiation and adherence among medicare beneficiaries with chronic myeloid leukemia","volume":"34","author":"Winn","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2019.04.003_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1200\/JOP.2014.001406","article-title":"Patient-oncologist cost communication, financial distress, and medication adherence","volume":"10","author":"Bestvina","year":"2014","journal-title":"J Oncol Pract"},{"issue":"8","key":"10.1016\/j.ygyno.2019.04.003_bb0065","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/cncr.29808","article-title":"Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors","volume":"122","author":"Kale","year":"2016","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ygyno.2019.04.003_bb0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."},{"issue":"10","key":"10.1016\/j.ygyno.2019.04.003_bb0075","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual. Life Res."},{"issue":"14","key":"10.1016\/j.ygyno.2019.04.003_bb0080","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1200\/JCO.2011.37.9511","article-title":"Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis","volume":"30","author":"Shankaran","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.ygyno.2019.04.003_bb0085","doi-asserted-by":"crossref","first-page":"e50-8","DOI":"10.1200\/JOP.2011.000418","article-title":"Understanding patients' attitudes toward communication about the cost of cancer care","volume":"8","author":"Bullock","year":"2012","journal-title":"J Oncol Pract"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819304986?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825819304986?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:48:26Z","timestamp":1758772106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825819304986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S0090825819304986"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.04.003","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Financial toxicity in gynecologic oncology","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2019.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}